News

Forbion closes the initial public offering of 11.0 million units of Forbion European Acquisition Corporation (FEAC) on the Nasdaq Global Market

décembre 14, 2021

Human Health

Company

Back

Naarden, The Netherlands, 14 December 2021 - Forbion is proud to announce today the closing of the initial public offering of 11.0 million units of Forbion European Acquisition Corporation (FEAC) on the Nasdaq Global Market at a price of $10.00 per unit, thereby raising a total of $110 million (or a total of $126.5 million including the underwriters’ over-allotment option). Each unit consists of one Class A ordinary share and one-third of one redeemable warrant, with each whole warrant exercisable to purchase one Class A ordinary share at a price of $11.50 per share. The units of FEAC are currently trading under the ticker symbol FRBNU on the Nasdaq Global Market. FEAC was formed for the purpose of effecting a business combination and it intends to focus its efforts to identify a prospective business combination opportunity on the life sciences industry.

Laura Asbjornsen portrait image
Head of Marketing & Communications
info@forbion.com